dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate

C71H90Cl4F3K2N13O11 — CID 157131263

IUPACdipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate
SMILESCN1CCC(CCCC(=O)NCc2cccc(Cl)c2F)CC1.CN1CCC(CN(CC(=O)NCc2cccc(Cl)c2F)C(=O)Cn2nc(C(N)=O)c3ccccc32)CC1.CN1CCC(CN)CC1.NC(=O)c1nn(CC(=O)O)c2ccccc12.O=C(CCl)CCc1cccc(Cl)c1F.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H30ClFN6O3.C17H24ClFN2O.C10H9Cl2FO.C10H9N3O3.C7H16N2.CH2O3.2K.H/c1-32-11-9-17(10-12-32)14-33(15-22(35)30-13-18-5-4-7-20(27)24(18)28)23(36)16-34-21-8-3-2-6-19(21)25(31-34)26(29)37;1-21-10-8-13(9-11-21)4-2-7-16(22)20-12-14-5-3-6-15(18)17(14)19;11-6-8(14)5-4-7-2-1-3-9(12)10(7)13;11-10(16)9-6-3-1-2-4-7(6)13(12-9)5-8(14)15;1-9-4-2-7(6-8)3-5-9;2-1-4-3;;;/h2-8,17H,9-16H2,1H3,(H2,29,37)(H,30,35);3,5-6,13H,2,4,7-12H2,1H3,(H,20,22);1-3H,4-6H2;1-4H,5H2,(H2,11,16)(H,14,15);7H,2-6,8H2,1H3;1,3H;;;/q;;;;;;2*+1;-1/p-1
InChIKeyHASHBBKKUUXWFP-UHFFFAOYSA-M
MW1578.58 g/mol
LogP2.30
Rot. Bonds24

About dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate

dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate (PubChem CID 157131263) has the molecular formula C71H90Cl4F3K2N13O11 and a molecular weight of 1578.58 g/mol. Its IUPAC name is dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate.

Molecular Properties

Compound Namedipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate
PubChem CID157131263
Molecular FormulaC71H90Cl4F3K2N13O11
Molecular Weight1578.58 g/mol
Exact Mass1575.49
IUPAC Namedipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate
SMILESCN1CCC(CCCC(=O)NCc2cccc(Cl)c2F)CC1.CN1CCC(CN(CC(=O)NCc2cccc(Cl)c2F)C(=O)Cn2nc(C(N)=O)c3ccccc32)CC1.CN1CCC(CN)CC1.NC(=O)c1nn(CC(=O)O)c2ccccc12.O=C(CCl)CCc1cccc(Cl)c1F.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H30ClFN6O3.C17H24ClFN2O.C10H9Cl2FO.C10H9N3O3.C7H16N2.CH2O3.2K.H/c1-32-11-9-17(10-12-32)14-33(15-22(35)30-13-18-5-4-7-20(27)24(18)28)23(36)16-34-21-8-3-2-6-19(21)25(31-34)26(29)37;1-21-10-8-13(9-11-21)4-2-7-16(22)20-12-14-5-3-6-15(18)17(14)19;11-6-8(14)5-4-7-2-1-3-9(12)10(7)13;11-10(16)9-6-3-1-2-4-7(6)13(12-9)5-8(14)15;1-9-4-2-7(6-8)3-5-9;2-1-4-3;;;/h2-8,17H,9-16H2,1H3,(H2,29,37)(H,30,35);3,5-6,13H,2,4,7-12H2,1H3,(H,20,22);1-3H,4-6H2;1-4H,5H2,(H2,11,16)(H,14,15);7H,2-6,8H2,1H3;1,3H;;;/q;;;;;;2*+1;-1/p-1
InChIKeyHASHBBKKUUXWFP-UHFFFAOYSA-M
XLogP2.30
TPSA339.80 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds24
Heavy Atoms104
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001578.58
LogP ≤ 52.30
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate?
The IUPAC name of dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate (CID 157131263) is dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate.
What is the SMILES notation for dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate?
The canonical SMILES for dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate is CN1CCC(CCCC(=O)NCc2cccc(Cl)c2F)CC1.CN1CCC(CN(CC(=O)NCc2cccc(Cl)c2F)C(=O)Cn2nc(C(N)=O)c3ccccc32)CC1.CN1CCC(CN)CC1.NC(=O)c1nn(CC(=O)O)c2ccccc12.O=C(CCl)CCc1cccc(Cl)c1F.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate?
The InChIKey is HASHBBKKUUXWFP-UHFFFAOYSA-M. The full InChI is InChI=1S/C26H30ClFN6O3.C17H24ClFN2O.C10H9Cl2FO.C10H9N3O3.C7H16N2.CH2O3.2K.H/c1-32-11-9-17(10-12-32)14-33(15-22(35)30-13-18-5-4-7-20(27)24(18)28)23(36)16-34-21-8-3-2-6-19(21)25(31-34)26(29)37;1-21-10-8-13(9-11-21)4-2-7-16(22)20-12-14-5-3-6-15(18)17(14)19;11-6-8(14)5-4-7-2-1-3-9(12)10(7)13;11-10(16)9-6-3-1-2-4-7(6)13(12-9)5-8(14)15;1-9-4-2-7(6-8)3-5-9;2-1-4-3;;;/h2-8,17H,9-16H2,1H3,(H2,29,37)(H,30,35);3,5-6,13H,2,4,7-12H2,1H3,(H,20,22);1-3H,4-6H2;1-4H,5H2,(H2,11,16)(H,14,15);7H,2-6,8H2,1H3;1,3H;;;/q;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate?
dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate has a molecular weight of 1578.58 g/mol, XLogP of 2.30, 24 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;2-(3-carbamoylindazol-1-yl)acetic acid;1-chloro-4-(3-chloro-2-fluorophenyl)butan-2-one;1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-[(1-methylpiperidin-4-yl)methyl]amino]-2-oxoethyl]indazole-3-carboxamide;N-[(3-chloro-2-fluorophenyl)methyl]-4-(1-methylpiperidin-4-yl)butanamide;hydride;(1-methylpiperidin-4-yl)methanamine;oxido formate is sourced from PubChem (CID 157131263), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).